Your session is about to expire
← Back to Search
Behavioural Intervention
Resistance Exercise for Healthy Children (Strength-Lip Trial)
N/A
Recruiting
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Healthy volunteer males and females ages 8 - 10 years
Be younger than 18 years old
Must not have
No history or ongoing neuromuscular diseases
No history or ongoing musculoskeletal injuries
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, following the intervention (9 weeks)
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to see how regular resistance exercise over 8 weeks can improve muscle strength and power, as well as look at changes in the leg muscle and cholesterol levels in children aged 8 to
Who is the study for?
This trial is for healthy children aged 8 to 10 years who are interested in participating in an 8-week strength training program. The study aims to understand how this exercise affects muscle strength, power, and fat content within muscles.
What is being tested?
The intervention being studied is resistance exercise training conducted three times a week over the course of eight weeks. Researchers will monitor changes in muscle strength, motor skills, and lipid profiles within a specific leg muscle called the vastus lateralis.
What are the potential side effects?
Resistance exercise is generally safe but may include typical side effects such as muscle soreness or fatigue following workouts. Serious side effects are rare in well-supervised programs for children.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a healthy child aged 8 to 10.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not have any neuromuscular diseases.
Select...
I have no history of bone or muscle injuries.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, following the intervention (9 weeks)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, following the intervention (9 weeks)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in muscular power of the leg extensors, as measured with isokinetic strength testing.
Secondary study objectives
Change from baseline in thigh muscle cross-sectional area
Other study objectives
Change from baseline in extramyocellular lipids of the vastus lateralis, as measure with magnetic resonance spectroscopy
Change from baseline in intramyocellular lipids of the vastus lateralis, as measure with magnetic resonance spectroscopy
Change from baseline in motor unit activation, as measured with surface electromyography decomposition.
+4 moreSide effects data
From 2015 Phase 3 trial • 50 Patients • NCT0218884918%
Pain
14%
Falls
14%
Gastroinftestinal symptoms
5%
Fever
100%
80%
60%
40%
20%
0%
Study treatment Arm
Creatine
Placebo
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Resistance exercise trainingExperimental Treatment1 Intervention
Group II: ControlActive Control1 Intervention
Find a Location
Who is running the clinical trial?
National Strength and Conditioning Association FoundationUNKNOWN
3 Previous Clinical Trials
84 Total Patients Enrolled
University of Kansas Medical CenterLead Sponsor
515 Previous Clinical Trials
177,124 Total Patients Enrolled